FPRX

Five Prime Therapeutics, Inc. News Headlines

$27.01
*  
0.33
1.21%
Get FPRX Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading FPRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Illumina Launches MiSeq FGx for Forensic DNA Analysis - Analyst Blog
1/22/2015 5:50:00 AM - Investopedia


5 Stocks Insiders Love Right Now: eHealth, Worthington Industries and More
1/21/2015 7:00:00 AM - TheStreet


Tuesday 1/20 Insider Buying Report: JPM, FPRX
1/20/2015 3:08:36 PM - BNK Invest


Could This Common Medicine Cabinet Supplement Be the Key to Increased Survival for Some Cancer Patie
1/18/2015 9:12:02 AM - Motley Fool


InsiderInsights.com Daily Round Up 1/16/15: WOR, EHTH, OPK, FPRX
1/18/2015 5:49:00 AM - Seeking Alpha


FPRX Prices Offering At $22/Share
1/6/2015 11:47:00 PM - RTT News


Five Prime Therapeutics Prices Public Offering At $22/share - Quick Facts
1/6/2015 9:04:00 PM - RTT News


Five Prime Plans Up To $75 Mln Stock Offering
1/5/2015 4:20:00 PM - RTT News


Will Biotech Fire On All Cylinders In 2015?
12/30/2014 4:15:00 PM - Seeking Alpha


MacroGenics Inks Deal with J&J for Blood Cancer Therapy - Analyst Blog
12/23/2014 3:00:00 PM - Zacks.com


3 Clinical Stage Biotech Stocks That Should Be on Your Watchlist in 2015
12/23/2014 7:07:02 AM - Motley Fool


MacroGenics Inks Deal with J&J for Blood Cancer Therapy - Analyst Blog
12/23/2014 3:00:00 AM - Investopedia


Five Prime To Present At Oppenheimer Conference; Webcast At 3:55 PM ET
12/10/2014 2:55:00 PM - RTT News


CLRB Spikes Over 13%, OVAS In Good Health, INCY, MYL Get FDA Nod
12/5/2014 12:20:00 AM - RTT News


Five Prime Therapeutics To Participate In Piper Jaffray Conference At 12:30PM ET
12/3/2014 11:30:00 AM - RTT News


Five Prime Therapeutics Up on Deal with Bristol-Myers - Analyst Blog
11/26/2014 4:30:00 PM - Zacks.com


Five Prime Therapeutics, Inc. (FPRX) in Focus: Stock Soars 31.4% - Tale of the Tape
11/25/2014 9:18:00 AM - Zacks.com


FPRX Gets High Five, CLRX Put On Notice, RNA Snapped Up, Natesto Changes Hands
11/25/2014 12:07:00 AM - RTT News


Monday Sector Leaders: Music & Electronics Stores, Drugs
11/24/2014 1:57:14 PM - BNK Invest


Five Prime Therapeutics (FPRX) Is Up Sharply After BMY Collaboration
11/24/2014 10:03:00 AM - RTT News


Bristol-Myers, Five Prime to Collaborate on Immunotherapy
11/24/2014 9:40:00 AM - Dow Jones Business News


Bristol-Myers, Five Prime Therapeutics Enter Into Clinical Collaboration Deal
11/24/2014 9:20:00 AM - RTT News


Five Prime Therapeutics' Novel Target Licensed by Glaxo - Analyst Blog
9/17/2014 5:00:00 PM - Zacks.com


Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha


Five Prime Therapeutics (FPRX) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
8/12/2014 7:51:00 AM - Zacks.com